Generex Biotechnology Corporation

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex...

finanznachrichten.de     18 hrs ago   2 related          

NEW YORK, Aug. 20 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation . Generex Biotechnology Corporation...                    

comments

Generex Biotechnology Sponsors Generex Oral-lyn Education & Training Symposium in Middle East

primenewswire.com     Jul 17, 2008   1 related          

WORCESTER, Mass., July 17, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, will sponsor a...                    

comments

Generex Biotechnology Generates New Sales of Approximately $300,000 Through the Generex MENA...

primenewswire.com     Jul 16, 2008   1 related          

WORCESTER, Mass., July 16, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, received a purchase order for the...                    

comments

Generex Biotechnology Generates New Sales of Approximately $300,000 Through the Generex MENA...

yahoo.com     Jul 17, 2008   1 related          

Wednesday July 16, 9:30 am ET Purchase Order Placed by a Distributor in Saudi Arabia WORCESTER, Mass., July 16, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News ), the leader in drug delivery for...                    

comments

Generex to Present Data At the 35th Annual Meeting & Exposition of the Controlled Release Society

primezone.com     Jul 10, 2008          

WORCESTER, Mass., July 10, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, is scheduled to...                    

comments

Generex to Present Data At the 35th Annual Meeting & Exposition of the Controlled Release Society...

yahoo.com     Jul 10, 2008          

WORCESTER, Mass., July 10, 2008 -- Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, is scheduled to make a poster presentation of clinical data at the...                    

comments

Investigational New Drug Application Submitted On Behalf of Generex Biotechnology for Combination...

primezone.com     Jul 9, 2008   2 related          

WORCESTER, Mass., July 9, 2008 (PRIME NEWSWIRE) -- An Investigational New Drug application (IND) has been submitted to the United States Food and Drug Administration (FDA) on behalf of Generex Biotechnology Corporation...                    

comments

Generex Provides Update On Dosing of Patients in Phase III Trial of Generex Oral-lyn

primenewswire.com     Jul 8, 2008   3 related          

WORCESTER, Mass., July 8, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has initiated...                    

comments

Generex Biotechnology Expands Mayo Clinic Collaboration for Vaccine Studies

primenewswire.com     Jun 26, 2008   2 related          

WORCESTER, Mass., June 26, 2008 (PRIME NEWSWIRE) -- Antigen Express, Inc. (www.antigenexpress.com), the wholly-owned immunotherapeutics subsidiary of Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), has signed...                    

comments

Generex Biotechnology Presented Data At The Endocrine Society's Annual Meeting

primezone.com     Jun 19, 2008   1 related          

WORCESTER, Mass., June 19, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, made a podium...                    

comments

1 2 3 4 next »